Study of using second-line chemotherapy plus Apatinib in local recurrence or metastatic breast cancer
Latest Information Update: 13 Oct 2017
At a glance
- Drugs Rivoceranib (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 13 Oct 2017 New trial record